Cas:373-02-4 Nickel – acetic acid (1:1) manufacturer & supplier

We serve Chemical Name:Nickel – acetic acid (1:1) CAS:373-02-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Nickel - acetic acid (1:1)

Chemical Name:Nickel – acetic acid (1:1)
CAS.NO:373-02-4
Synonyms:anhydrous nickel acetate;Acetic acid, nickel salt (1:1);nickelous diacetate;Nickel diacetate;Nickel – acetic acid (1:1);EINECS 206-761-7
Molecular Formula:C2H4NiO2
Molecular Weight:118.745
HS Code:2915299090

Physical and Chemical Properties:
Melting point:1555°C
Boiling point:117.1ºC at 760 mmHg
Density:9.50 lb/gal
Index of Refraction:
PSA:37.30000
Exact Mass:117.956474
LogP:0.09090

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like anhydrous nickel acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 206-761-7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nickel – acetic acid (1:1) Use and application,nickelous diacetate technical grade,usp/ep/jp grade.


Related News: It is delivered to hospitals and pharmacies until it reaches the patient. Nickel – acetic acid (1:1) manufacturer It is delivered to hospitals and pharmacies until it reaches the patient. Nickel – acetic acid (1:1) supplier It is delivered to hospitals and pharmacies until it reaches the patient. Nickel – acetic acid (1:1) vendor The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. Nickel – acetic acid (1:1) factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.